RESUMEN
Tritrichomonas foetus infects the bovine urogenital tract, causing bovine trichomoniasis. Significant economic losses may occur due to infertility and abortion among cattle. Trichomonas vaginalis is the causative agent of trichomoniasis; the most common but overlooked non-viral sexually transmitted disease worldwide. Human and bovine trichomoniasis present treatment restrictions and efforts to identify new alternatives are essential. The present study evaluated the anti-trichomonads activities of seven fractions from northwest endemic plant Manilkara rufula. Flavonoids and condensed tannins were identified from these fractions by LC-DAD-MS/MS and MALDI-MS/MS. Altogether, the results demonstrated for the first time the structural description of tannins from leaves of M. rufula and the relation of these compounds with anti-T. vaginalis and anti-T. foetus activities. Overall, this report reveals the potential of M. rufula fractions against both parasites and shows new alternatives to treat the infection caused by trichomonads.
Asunto(s)
Antitricomonas/farmacología , Flavonoides/farmacología , Manilkara/química , Extractos Vegetales/farmacología , Taninos/farmacología , Trichomonas vaginalis/efectos de los fármacos , Tritrichomonas foetus/efectos de los fármacos , Antitricomonas/química , Antitricomonas/aislamiento & purificación , Brasil , Línea Celular , Supervivencia Celular , Cromatografía Liquida , Células Epiteliales/efectos de los fármacos , Flavonoides/química , Flavonoides/aislamiento & purificación , Células HeLa , Humanos , Estructura Molecular , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Hojas de la Planta/química , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Taninos/química , Taninos/aislamiento & purificación , Trichomonas vaginalis/fisiología , Tritrichomonas foetus/fisiologíaRESUMEN
The Amaryllidaceae family is known by its ornamental and medicinal value and has attracted considerable attention due to the content of alkaloids of its species, which showed interesting biological properties. The present study evaluated the anti-Trichomonas vaginalis activity of eighteen extracts (12.5 to 0.19 mg/mL) and six isolated alkaloids (125 to 1.9 µg/mL) from Amaryllidaceae species. The alkaloids diminished the trophozoites viability (from 15 to 40 %). The extracts from Hippeastrum breviflorum demonstrated the highest anti-T. vaginalis activity (viability was 60 % reduced), and a bioguided study was conducted. Six fractions with antiprotozoal activity had lycorine and lycosinine as major components suggesting a synergistic effect, taking into account the higher anti-T. vaginalis activity of extracts when compared to isolated alkaloids. Our results point out the antiprotozoal potential of the Amaryllidaceae species against T. vaginalis. This parasite causes trichomonosis, the most prevalent nonviral sexually transmitted diseases (STD) worldwide and a public health problem that requires new therapeutic alternatives as well bioactive natural products.
Asunto(s)
Antitricomonas/química , Antitricomonas/farmacología , Liliaceae/química , Trichomonas vaginalis/efectos de los fármacos , 5'-Nucleotidasa/antagonistas & inhibidores , Adenosina/metabolismo , Alcaloides/farmacología , Alcaloides de Amaryllidaceae/química , Alcaloides de Amaryllidaceae/farmacología , Fraccionamiento Químico , Evaluación Preclínica de Medicamentos , Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/farmacología , Nucleósido-Trifosfatasa/antagonistas & inhibidores , Fenantridinas/farmacología , Extractos Vegetales/química , Extractos Vegetales/farmacología , Raíces de Plantas/química , Trofozoítos/efectos de los fármacosRESUMEN
Trichomoniasis vaginalis is now an important worldwide health problem. Metronidazole has so far been used in treatment, but the metronidazole-resistant strains and unpleasant adverse effects have been developed. Treatment of patients with metronidazole refractory vaginal trichomoniasis constitutes a major therapeutic challenge and treatment options are extremely limited. In the present study, 33 metronidazole-resistant T. vaginalis females were treated with a combined course of metronidazole and tinidazole. Those still resistant to the combined treatment were given Commiphora molmol (Myrrh) as two capsules for six to eight successive days on an empty stomach two hours before breakfast. Also, natural plant extract purified from (Roman) was in-vitro investigated for its efficacy against T. vaginalis on fresh Diamond media. The anti-trichomoniasis vaginalis activity of both P. granatum (in-vitro) and C. molmol (in-vivo) extracts gave promising results.
Asunto(s)
Commiphora/química , Lythraceae/química , Extractos Vegetales/uso terapéutico , Vaginitis por Trichomonas/tratamiento farmacológico , Animales , Antitricomonas/química , Antitricomonas/uso terapéutico , Relación Dosis-Respuesta a Droga , Resistencia a Medicamentos , Femenino , Humanos , Metronidazol/farmacología , Extractos Vegetales/química , Tinidazol/farmacología , Trichomonas vaginalis/efectos de los fármacosRESUMEN
Bond-based quadratic indices, new TOMOCOMD-CARDD molecular descriptors, and linear discriminant analysis (LDA) were used to discover novel lead trichomonacidals. The obtained LDA-based quantitative structure-activity relationships (QSAR) models, using nonstochastic and stochastic indices, were able to classify correctly 87.91% (87.50%) and 89.01% (84.38%) of the chemicals in training (test) sets, respectively. They showed large Matthews correlation coefficients of 0.75 (0.71) and 0.78 (0.65) for the training (test) sets, correspondingly. Later, both models were applied to the virtual screening of 21 chemicals to find new lead antitrichomonal agents. Predictions agreed with experimental results to a great extent because a correct classification for both models of 95.24% (20 of 21) of the chemicals was obtained. Of the 21 compounds that were screened and synthesized, 2 molecules (chemicals G-1, UC-245) showed high to moderate cytocidal activity at the concentration of 10 microg/ml, another 2 compounds (G-0 and CRIS-148) showed high cytocidal activity only at the concentration of 100 microg/ml, and the remaining chemicals (from CRIS-105 to CRIS-153, except CRIS-148) were inactive at these assayed concentrations. Finally, the best candidate, G-1 (cytocidal activity of 100% at 10 microg/ml) was in vivo assayed in ovariectomized Wistar rats achieving promising results as a trichomonacidal drug-like compound.
Asunto(s)
Antitricomonas/química , Antitricomonas/farmacología , Diseño Asistido por Computadora , Evaluación Preclínica de Medicamentos/métodos , Programas Informáticos , Trichomonas vaginalis/efectos de los fármacos , Adulto , Animales , Antitricomonas/uso terapéutico , Análisis Discriminante , Farmacorresistencia Bacteriana , Femenino , Humanos , Estructura Molecular , Ovariectomía , Ratas , Ratas Wistar , Tricomoniasis/tratamiento farmacológicoRESUMEN
Trichomoniasis is now an important health problem in developing countries. Although metronidazole has so far been widely used to treat this disease, the prevalence of metronidazole-resistant protozoa and unpleasant adverse effects have been found. In this study, natural products purified from Thai plants were, therefore, investigated for their effectiveness against Trichomonas vaginalis. The minimal inhibitory concentrations for all beta-glycosides against Trichomonas vaginalis at 24 h were in a range of 6.25-12.5 microM. In addition, torvoside A and H were found to be more potent than their corresponding aglycones, deglucosylated torvoside A and H, while other beta-glycosides were generally as active as their corresponding aglycones. The cytotoxicity of these compounds was also determined. Except for dalcochinin, none of the tested compounds showed cytotoxicity against Vero and cancer cell lines (KB and MCF-7), having IC(50) values greater than 50 microg/ml. In conclusion, beta-glycosides and several aglycones showed selective inhibition against Trichomonas vaginalis without harmful effect to mammalian cells.
Asunto(s)
Antitricomonas/farmacología , Glicósidos/farmacología , Plantas Medicinales/química , Trichomonas vaginalis/efectos de los fármacos , Animales , Antitricomonas/química , Antitricomonas/toxicidad , Línea Celular Tumoral/efectos de los fármacos , Chlorocebus aethiops , Glicósidos/química , Glicósidos/toxicidad , Humanos , Concentración 50 Inhibidora , Pruebas de Sensibilidad Parasitaria , Tailandia , Células Vero/efectos de los fármacosRESUMEN
Crude methanolic extracts from 22 Mexican medicinal plants were screened for antitrichomonal activity against Trichomonas vaginalis, which is the etiological agent of trichomoniasis. Among the plants tested Carica papaya and Cocos nucifera showed the best antitrichomonal activity with IC(50) values of 5.6 and 5.8 microg/ml, respectively. The extracts of Bocconia frutescens, Geranium mexicanum, and Lygodium venustum showed moderate activity with IC(50) values ranging from 30.9 to 60.9 microg/ml. All the other plant extracts were inactive (IC(50)>100 microg/ml). All extracts tested were less active than metronidazole (IC(50) 0.037 microg/ml), an antiprotozoal drug used as positive control. The results of the antiprotozoal screening support the popular uses of five of the plants tested for the treatment of some urogenital tract disorders in Mexican traditional medicine. However, seeds of Carica papaya and aerial parts of Bocconia frutescens should be used in herbal medicine with care to avoid toxicity.
Asunto(s)
Antitricomonas/farmacología , Extractos Vegetales/farmacología , Plantas Medicinales/química , Trichomonas vaginalis/efectos de los fármacos , Trofozoítos/efectos de los fármacos , Animales , Antiprotozoarios/farmacología , Antitricomonas/química , Carica/química , Cocos/química , Geranium/química , Concentración 50 Inhibidora , Metanol/química , Metronidazol/farmacología , México , Papaveraceae/química , Componentes Aéreos de las Plantas/química , Extractos Vegetales/química , Plantas Medicinales/clasificación , Ratas , Semillas/química , Trichomonas vaginalis/crecimiento & desarrollo , Trofozoítos/crecimiento & desarrolloRESUMEN
The study investigated spermicidal and antitrichomonas activities of selective serotonin reuptake inhibitor (SSRI) antidepressants with a view to generate new lead for development of dual-function spermicidal microbicides, which is an urgent global need. Fluoxetine, Sertraline, and Fluvoxamine exhibited both spermicidal and anti-STI (antitrichomonas) activities in vitro, whereas Paroxetine and Citalopram showed only the spermicidal activity. Fluoxetine exhibited better activity profile than the other antidepressant drugs with its spermicidal and antitrichomonas activities being comparable to that of the OTC contraceptive Nonoxynol-9. The non-detergent nature of Fluoxetine and a much lower spermicidal ED50 value (than N-9) may add considerably to its merit as a candidate for microbicidal contraceptive. Thus, the antidepressants exhibiting both spermicidal and antitrichomonas activities might provide useful lead for the development of novel, dual-function spermicidal contraceptives.
Asunto(s)
Antidepresivos/farmacología , Antitricomonas/farmacología , Inhibidores Selectivos de la Recaptación de Serotonina/farmacología , Espermicidas/farmacología , Espermatozoides/efectos de los fármacos , Trichomonas vaginalis/efectos de los fármacos , Animales , Antidepresivos/química , Antitricomonas/química , Evaluación Preclínica de Medicamentos , Fluoxetina/química , Fluoxetina/farmacología , Fluvoxamina/química , Fluvoxamina/farmacología , Humanos , Técnicas In Vitro , Masculino , Estructura Molecular , Inhibidores Selectivos de la Recaptación de Serotonina/química , Sertralina/química , Sertralina/farmacología , Espermicidas/química , Relación Estructura-ActividadRESUMEN
Dorstenia barteri and D. convexa extracts and some isolated components of the former were investigated for effectiveness against Trichomonas gallinarum and compared with quercetin and quercitrin. The antioxidant activity of the extracts/compounds was also determined. The minimum lethal concentrations (MLCs) for the extract of D. barteri leaves and twigs at 24 h were found to be 15.625 and 15.625 microg/ml, respectively. However, the MLCs of the leaf and twig extract of D. convexa were 125 and 437.5 microg/ml, respectively. The prenylated and geranylated chalcones were as active as the prenylated flavones, 6-prenylapigenin and the diprenylated derivative 6,8-diprenyleridictyol. The order of the antitrichomonal activity of the compounds at 24 h was: quercetin (0.121 microg/ml) > quercitrin (0.244 microg/ml) > or = bartericin B (0.244 microg/ml) > bartericin A (0.73 microg/ml) > stigmasterol (0.98 microg/ml) > 6,8-diprenyleridictyol = isobavachalcone = dorsmanin F (31.25 microg/ml). D. barteri extracts, quercitrin, and bartericin A, and the prenylated flavonoids had potent antioxidant properties. The twig extract of D. barteri was more potent than the leaf extract. Moderate (EC50 >50 microg/ml) and high (EC50 <50 microg/ml) antioxidant activities were detected in the leaf and twig extracts of D. barteri and the prenylated flavonoids. Prenylated flavonoids and the isolated compounds with antioxidant properties described here may account for the anti-inflammatory action of these extracts. The antitrichomonal and antioxidant activities shown by the extracts and compounds in this study are consistent with the ethnomedicinal and local use of the Dorstenia species studied.
Asunto(s)
Antioxidantes/farmacología , Antitricomonas/farmacología , Flavonoides/farmacología , Moraceae/química , Trichomonas/efectos de los fármacos , Animales , Antioxidantes/química , Antioxidantes/aislamiento & purificación , Antitricomonas/química , Antitricomonas/aislamiento & purificación , Evaluación Preclínica de Medicamentos , Flavonoides/química , Flavonoides/aislamiento & purificación , Pruebas de Sensibilidad Parasitaria , Extractos Vegetales/farmacología , Quercetina/análogos & derivados , Quercetina/farmacologíaRESUMEN
A computational (virtual) screening test to identify potential trichomonacidals has been developed. Molecular structures of trichomonacidal and non-trichomonacidal drugs were represented using stochastic and non-stochastic atom-based quadratic indices and a linear discrimination analysis (LDA) was trained to classify molecules regarding their antiprotozoan activity. Validation tests revealed that our LDA-QSAR models recognize at least 88.24% of trichomonacidal lead-like compounds and suggest using this methodology in virtual screening protocols. These classification functions were then applied to find new lead antitrichomonal compounds. In this connection, the biological assays of eight compounds, selected by computational screening using the present models, give good results (87.50% of good classification). In general, most of the compounds showed high activity against Trichomonas vaginalis at the concentration of 100 microg/ml and low cytotoxicity to this concentration. In particular, two heterocyclic derivatives (VA7-67 and VA7-69) maintained their efficacy at 10 microg/ml with an important trichomonacidal activity (100.00% of reduction), but it is remarkable that the compound VA7-67 did not show cytotoxic effects in macrophage cultivations. This result opens a door to a virtual study considering a higher variability of the structural core already evaluated, as well as of other chemicals not included in this study.
Asunto(s)
Antitricomonas/química , Evaluación Preclínica de Medicamentos/métodos , Compuestos Heterocíclicos/química , Interfaz Usuario-Computador , Animales , Antitricomonas/clasificación , Simulación por Computador , Relación Estructura-Actividad , Trichomonas vaginalis/efectos de los fármacosRESUMEN
Dorstenia barteri and D. convexa extracts and some isolated components of the former were investigated for effectiveness against Trichomonas gallinarum and compared with quercetin and quercitrin. The antioxidant activity of the extracts/compounds was also determined. The minimum lethal concentrations (MLCs) for the extract of D. barteri leaves and twigs at 24 h were found to be 15.625 and 15.625 æg/ml, respectively. However, the MLCs of the leaf and twig extract of D. convexa were 125 and 437.5 æg/ml, respectively. The prenylated and geranylated chalcones were as active as the prenylated flavones, 6-prenylapigenin and the diprenylated derivative 6,8-diprenyleridictyol. The order of the antitrichomonal activity of the compounds at 24 h was: quercetin (0.121 æg/ml) > quercitrin (0.244 æg/ml) > or = bartericin B (0.244 æg/ml) > bartericin A (0.73 æg/ml) > stigmasterol (0.98 æg/ml) > 6,8-diprenyleridictyol = isobavachalcone = dorsmanin F (31.25 æg/ml). D. barteri extracts, quercitrin, and bartericin A, and the prenylated flavonoids had potent antioxidant properties. The twig extract of D. barteri was more potent than the leaf extract. Moderate (EC50 >50 æg/ml) and high (EC50 <50 æg/ml) antioxidant activities were detected in the leaf and twig extracts of D. barteri and the prenylated flavonoids. Prenylated flavonoids and the isolated compounds with antioxidant properties described here may account for the anti-inflammatory action of these extracts. The antitrichomonal and antioxidant activities shown by the extracts and compounds in this study are consistent with the ethnomedicinal and local use of the Dorstenia species studied.